Afaxys LLC, a US-based pharmaceutical company, announced on Tuesday that it has named Kelly R Culwell, MD, MPH, FACOG, as its new senior vice president and chief medical officer.
In the new role, Dr Culwell will serve as a member of the company's executive team and will offer guidance on the strategic direction and implementation of the firm's clinical, medical and regulatory objectives that will build on and sustain present and future portfolio assets.
Dr Culwell has served as CMO of Evofem Biosciences for the past seven years and CMO of WCG and Planned Parenthood of the Pacific Southwest among other roles and organisations.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer